Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PLGA nanoparticle formulation of RK-33: an RNA helicase inhibitor against DDX3.
Bol GM, Khan R, Heerma van Voss MR, Tantravedi S, Korz D, Kato Y, Raman V. Bol GM, et al. Among authors: heerma van voss mr. Cancer Chemother Pharmacol. 2015 Oct;76(4):821-7. doi: 10.1007/s00280-015-2851-3. Epub 2015 Sep 2. Cancer Chemother Pharmacol. 2015. PMID: 26330329 Free PMC article.
Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment.
Heerma van Voss MR, Vesuna F, Bol GM, Afzal J, Tantravedi S, Bergman Y, Kammers K, Lehar M, Malek R, Ballew M, Ter Hoeve N, Abou D, Thorek D, Berlinicke C, Yazdankhah M, Sinha D, Le A, Abrahams R, Tran PT, van Diest PJ, Raman V. Heerma van Voss MR, et al. Oncogene. 2018 Jan 4;37(1):63-74. doi: 10.1038/onc.2017.308. Epub 2017 Sep 4. Oncogene. 2018. PMID: 28869602 Free PMC article.
Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
Bol GM, Vesuna F, Xie M, Zeng J, Aziz K, Gandhi N, Levine A, Irving A, Korz D, Tantravedi S, Heerma van Voss MR, Gabrielson K, Bordt EA, Polster BM, Cope L, van der Groep P, Kondaskar A, Rudek MA, Hosmane RS, van der Wall E, van Diest PJ, Tran PT, Raman V. Bol GM, et al. Among authors: van der groep p, van der wall e, van diest pj, heerma van voss mr. EMBO Mol Med. 2015 May;7(5):648-69. doi: 10.15252/emmm.201404368. EMBO Mol Med. 2015. PMID: 25820276 Free PMC article.
RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3.
Xie M, Vesuna F, Tantravedi S, Bol GM, Heerma van Voss MR, Nugent K, Malek R, Gabrielson K, van Diest PJ, Tran PT, Raman V. Xie M, et al. Among authors: heerma van voss mr. Cancer Res. 2016 Nov 1;76(21):6340-6350. doi: 10.1158/0008-5472.CAN-16-0440. Epub 2016 Sep 12. Cancer Res. 2016. PMID: 27634756 Free PMC article.
The prognostic effect of DDX3 upregulation in distant breast cancer metastases.
Heerma van Voss MR, Schrijver WA, Ter Hoeve ND, Hoefnagel LD, Manson QF, van der Wall E, Raman V, van Diest PJ; Dutch Distant Breast Cancer Metastases Consortium. Heerma van Voss MR, et al. Clin Exp Metastasis. 2017 Jan;34(1):85-92. doi: 10.1007/s10585-016-9832-8. Epub 2016 Dec 20. Clin Exp Metastasis. 2017. PMID: 27999982 Free PMC article.
Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer.
Heerma van Voss MR, Vesuna F, Bol GM, Meeldijk J, Raman A, Offerhaus GJ, Buerger H, Patel AH, van der Wall E, van Diest PJ, Raman V. Heerma van Voss MR, et al. Onco Targets Ther. 2017 Jul 17;10:3501-3513. doi: 10.2147/OTT.S140639. eCollection 2017. Onco Targets Ther. 2017. PMID: 28761359 Free PMC article.
Targeting RNA helicases in cancer: The translation trap.
Heerma van Voss MR, van Diest PJ, Raman V. Heerma van Voss MR, et al. Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):510-520. doi: 10.1016/j.bbcan.2017.09.006. Epub 2017 Sep 28. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28965870 Free PMC article. Review.
17 results